Domain Registration

Ferozsons introduces first-ever vaccine to combat Hepatitis E

  • July 29, 2021

LAHORE – COVID-19 changed the landscape of the health sector all around the world. As the deadly virus struck the world, health officials were alarmed. In the past one year, the focus on health concerns has increased significantly. One major epidemic that has existed for a very long time is Hepatitis E. Ferozsons Laboratories Limited, a leading pharmaceutical company of the country, has introduced the first vaccine for Hepatitis E in Pakistan. This vaccine is beneficial for women who are looking to expand their families. Ferozsons through this great initiative is committed to end Hepatitis E enabling women to have a safe pregnancy. The development of the first ever vaccine in collaboration with Xiamen Innovax Biotech to combat Hepatitis E will have a positive impact on the health of women as well as the population in general. This vaccination has an efficacy of 93.8% in 1-year follow up and the long-term efficacy is 93.3%. The Hecolin HEV vaccine is safe for the mother as well as the fetus. According to Dr Javaid Iqbal Farooqi, a senior hepatology and gastroenterology specialist, “The vaccine for Hepatitis E is vital especially for young females of child-bearing age, patients of chronic liver disease and the elderly.”

 He added, “This vaccine is extremely effective and is going to help limit Hepatitis E cases in Pakistan. I encourage everyone, especially females to get themselves vaccinated for a healthier future.”

Dr. Khalid Hameed, who specializes in hepatology and gastroenterology, also commented on the initiative and stated that, “This vaccine is a much needed addition to our arsenal, and will help females have safer pregnancies. It is pertinent that all young women get themselves vaccinated. This will be beneficial for the mothers as well as their children.”

Article source:

Related News